NCT03833700 2026-02-27A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)Eisai Inc.Phase 1 Active not recruiting70 enrolled
NCT03093116 2025-07-10TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 2 FDA